Establishment of a transdermal infection model with Leishmania amazonensis.

backgroundLeishmaniasis, a parasitic disease caused by Leishmania protozoa, has various clinical forms and is endemic in Brazil. Traditional experimental infection methods using intradermal and subcutaneous needles do not resemble natural sand fly transmission and are associated with risks of laboratory accidents owing to the use of low-gauge needles. In this study, we investigated the application of microneedles for transdermal (TD) infections to better replicate the deposition of parasites observed in the natural infection environment while ensuring safe handling in the laboratory.

methodsInitial experiments involved inducing TD infections using 1-, 7- or 12-microneedle cartridges, compared with inducing conventional intradermal (ID) infections in the ears of BALB/c mice. Subsequent tests used a 12-microneedle cartridge at different tissue depths (0.25, 0.5, 0.75, 1.0 and 1.5 mm), followed by challenge with different doses of Leishmania amazonensis. In addition, histology and flow cytometry studies were performed 30 min post-infection.

resultsTransdermal infections produced similar lesion development and parasite loads as ID infections. More tissue destruction was induced using the 1- or 7-microneedle cartridge compared to the 12-microneedle cartridge and ID infection. Infection was successfully established at all microneedle depths (0.25, 0.5, 0.75 and 1.0 mm), resulting in comparable lesion thickness across the different experimental groups, with no statistically significant differences observed. The parasite load and lesion thickness were dependent on the inoculum size in the ear infection via the TD route, with efficient lesion progression using 2 × 10

conclusionsThis novel microneedle infection model enables efficient challenge and reduces risks during animal experimentation. This technique holds promise for future studies of leishmaniasis therapy and vaccine development.